Proteomics Market Research Report: by Equipment (Chromatography, Mass Spectroscopy, Protein Microarray), Services (Laboratory Services, Data Analysis & Services), Application (Drug Discovery, Clinical Diagnosis) - Forecast Till 2030

Proteomics Market Overview
 
Proteomics Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 67.5 billion by 2030 and Proteomics Market is projected to grow at a CAGR of 12.3% over the forecast period 2022-2030. Proteomics is the experimentation with protein structure and function. At the primary level, proteomics deals with the topics, such as which proteins are demonstrated, when and where they are demonstrated, what are their structures in both inactive and active states, what roles they perform in the life of the cell, and how they communicate with other proteins and molecules. The covid-19 outburst that initiated in the Wuhan city of China has now been widespread worldwide. Almost every country is dealing with outbursts. Most of the markets across the world are decreasing due to covid-19. However, covid-19 has adversely affected several healthcare-related markets. This pandemic is projected to present growth opportunities for the proteomics market in the future across the world.

Segmentation:

The Proteomics Market has been segmented into equipment, service and applicationThe market, on the basis of equipment, has been segmented into chromatography, mass spectroscopy, protein microarray, x-ray crystallography, protein fractionation and others.The market, by services, has been segmented into laboratory services and data analysis & services. The laboratory services segment accounted for the largest market share owing to its benefits in effective diagnosis and research for drug discovery. Data analysis and services is expected to register the highest CAGR owing to increasing demand for data analytics.The market, by application, has been segmented into drug discovery, clinical diagnosis and others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Proteomics Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European Proteomics Market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The Proteomics Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Proteomics market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players:

GENERAL ELECTRIC COMPANY, Bio-Rad Laboratories, Inc., Danaher, Siemens Ltd., Thermo Fisher Scientific Inc. Inc., Agilent Technologies, Inc., Genzyme Corporation, Biognosys AG, Bruker, Luminex Corporation, Merck KGaA, PerkinElmer Inc., WATERS, Caprion Biosciences Inc. and others are some of the key players in the Proteomics Market.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the proteomics market owing to rising funding from government, rising awareness regarding applications of proteomics, cost effectiveness and increasing demand for personalized medicines. According to a report published in a journal named Leukemia Research in November 2017, personalized medicines improve life of cancer patients by 7 months at USD 32,000.

Europe is expected to hold the second largest position in the Proteomics Market. The market growth in this region is attributed to rising cancer research activities and government support. The proteomics market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and the Rest of the Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the increasing demand for personalized medicine due to rising prevalence of cancer and other such diseases and presence of large number of manufacturers of personalized medicines in the region. According to a report published by the National Institute of Cancer Prevention and Research (NICPR), around 2.25 million people in India are living with cancer in 2018.

The Middle East & Africa are expected to hold the least share of the market. The proteomics market growth in this region is expected to be driven by a developing healthcare infrastructure.

Proteomics Market, by Equipment:

• Chromatography


• Mass Spectroscopy


• Protein Microarray


• X-ray Crystallography


• Protein Fractionation


• Others

Proteomics Market, by Services:

•       Laboratory Service


•       Data Analysis and Services

Proteomics Market, by Application:

•      Drug Discovery


•      Clinical Diagnosis


•      Others

Proteomics Market, by Region:

• Americas
  
  
  
  •   North America
    
    
    
    •  US
    
    
    •  Canada
    
    
    
    
  
  
  •  South America
  
  
  
  


• Europe
  
  
  
  •  Western Europe
    
    
    
    •  Germany
    
    
    •  France
    
    
    •  Italy
    
    
    •  Spain
    
    
    •  UK
    
    
    •  Rest of Western Europe
    
    
    
    
  
  
  •   Eastern Europe
  
  
  
  


• Asia-Pacific
  
  
  
  •  Japan
  
  
  •  China
  
  
  •  India
  
  
  •  Australia
  
  
  •  South Korea
  
  
  •  Rest of Asia-Pacific
  
  
  
  


• The Middle East & Africa
  
  
  
  •  Middle East
  
  
  •  Africa
  
  
  
  

Proteomics Market, by Key Players:

•       Hoffmann-La Roche Ltd


•       GENERAL ELECTRIC COMPANY


•       Bio-Rad Laboratories, Inc.


•       Danaher


•       Siemens Ltd.


•       Thermo Fisher Scientific Inc. Inc.


•       Agilent Technologies, Inc.


•       Genzyme Corporation


•       Biognosys AG


•       Bruker


•       Luminex Corporation


•       Merck KGaA


•       PerkinElmer Inc.


•       WATERS


•       Caprion Biosciences Inc.

Recent Development

The improvement of therapeutic and preventive strategies needs a correct understanding of the role that proteins perform in the SARS-CoV infection process and the continuation of covid-19. A large array of recognition and detachment techniques can separate proteins from complex mixtures, facilitating the research of protein-protein interaction, temporal expression structures, and cellular and subcellular distributions. Protein detection applying MS techniques has become the limitation of the other proteomic technologies that need a large amount of purified protein for research. On the basis of MS viral peptide identification has lastly been applied to profile viral proteins that affect respiratory pathways. Nowadays, reverse transcription-polymerase chain reaction is the initial method applied to identify viral genes in covid-19 positive patients, whereas the RT-PCR technique is not sensitive enough to identify these covid-19 genes.

Intended Audience:

• Pharmaceutical Companies


• Research and Development Organization


• Oncology Laboratories


• Healthcare Organizations


• Academics and Research Institutes